ArticleFrontiers in public health2026
The geography of waiting: surveillance latency as the hidden driver of Ebola risk in East Africa.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ebola virus disease remains a persistent public health threat in East Africa, yet preparedness strategies continue to emphasise response after outbreaks are recognised rather than the period preceding detection. This Perspective argues that surveillance latency the cumulative delay between the earliest clinically meaningful signal and organised public health action is a critical but insufficiently measured determinant of Ebola risk. Although diagnostic and reporting delays have been widely documented, they are often treated as isolated operational challenges. We introduce the concept of the geography of waiting, an integrative framework that links biological, clinical, diagnostic, administrative and community delays to spatial inequalities in physical, technical and relational infrastructure. Unequal access to diagnostics, transportation, laboratory networks, trusted communication channels and community reporting systems creates substantial variation in detection timelines across settings. Where surveillance latency is prolonged, transmission may continue undetected, increasing the likelihood of larger and more complex outbreaks. Drawing on evidence from outbreaks in Uganda, the Democratic Republic of the Congo, Guinea and Rwanda, we examine the mechanisms underlying delayed detection and consider them alongside performance frameworks such as Uganda's 7-1-7 strategy. We propose a practical approach that integrates syndromic and event-based surveillance, decentralised molecular testing, community early-warning systems and regional data sharing. Because shorter detection intervals are associated with smaller eventual outbreaks in the cases reviewed here, reducing surveillance latency is a plausible high-value investment for Ebola preparedness, although this remains a hypothesis pending formal economic evaluation rather than an established finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.